Detlef F. Albrecht
Net Worth

Last updated:

What is Detlef F. Albrecht net worth?

The estimated net worth of Dr. Detlef F. Albrecht is at least $2,528,550 as of 1 Sep 2020. He has earned $22,800 from insider trading and has received compensation worth at least $2,505,750 in Satsuma Pharmaceuticals, Inc..

What is the salary of Detlef F. Albrecht?

Dr. Detlef F. Albrecht salary is $501,150 per year as Chief Medical Officer in Satsuma Pharmaceuticals, Inc..

How old is Detlef F. Albrecht?

Dr. Detlef F. Albrecht is 64 years old, born in 1961.

What stocks does Detlef F. Albrecht currently own?

As insider, Dr. Detlef F. Albrecht owns shares in one company:

Company Title Shares Price per share Total value
Satsuma Pharmaceuticals, Inc. (STSA) Chief Medical Officer 20,212 $0 $0

What does Satsuma Pharmaceuticals, Inc. do?

Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can be self-administered with proprietary pre-filled, single-use, and nasal delivery device. Satsuma Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.

Detlef F. Albrecht insider trading

Satsuma Pharmaceuticals, Inc.

Dr. Detlef F. Albrecht has made 15 insider trades in 2020, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 1,600 units of STSA stock on 14 Apr 2020. As of 1 Sep 2020 he still owns at least 20,212 units of STSA stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 1,000 $4.56 $4,560
Sale
Stock Option (Right to Buy) 1,000 $4.56 $4,560
Sale
Common Stock 1,000 N/A N/A
Sale
Stock Option (Right to Buy) 1,000 N/A N/A
Option
Common Stock 1,000 $11.56 $11,560
Option
Common Stock 1,000 $22.99 $22,986
Sale
Common Stock 800 N/A N/A
Option
Common Stock 1,000 $26.83 $26,831
Sale
Stock Option (Right to Buy) 1,000 N/A N/A
Option
Common Stock 1,000 $17.56 $17,561
Sale
Common Stock 300 N/A N/A
Option
Common Stock 1,000 $4.56 $4,560
Sale
Common Stock 1,000 N/A N/A
Sale
Stock Option (Right to Buy) 1,000 $4.56 $4,560
Option
Common Stock 1,000 N/A N/A
Sale
Stock Option (Right to Buy) 1,000 N/A N/A
Sale
Common Stock 1,000 N/A N/A
Sale
Common Stock 1,600 $2.28 $3,648
Sale
Stock Option (Right to Buy) 800 $4.56 $3,648
Option
Common Stock 1,600 $4.56 $7,296
Sale
Stock Option (Right to Buy) 200 $4.56 $912
Sale
Common Stock 400 $2.28 $912
Option
Common Stock 200 N/A N/A
Option
Stock Option (Right to Buy) 1,000 $4.56 $4,560
Option
Common Stock, $0.0001 par value 1,000 $4.56 $4,560
Sale
Common Stock, $0.0001 par value 1,000 $4.56 $4,560

Satsuma Pharmaceuticals key executives

Satsuma Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: